JP2021527104A5 - - Google Patents

Info

Publication number
JP2021527104A5
JP2021527104A5 JP2020569792A JP2020569792A JP2021527104A5 JP 2021527104 A5 JP2021527104 A5 JP 2021527104A5 JP 2020569792 A JP2020569792 A JP 2020569792A JP 2020569792 A JP2020569792 A JP 2020569792A JP 2021527104 A5 JP2021527104 A5 JP 2021527104A5
Authority
JP
Japan
Prior art keywords
sugarcane
fiber material
bowel disease
material extracted
inflammatory bowel
Prior art date
Application number
JP2020569792A
Other languages
English (en)
Japanese (ja)
Other versions
JPWO2019237152A5 (https=
JP7385930B2 (ja
JP2021527104A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/AU2019/050604 external-priority patent/WO2019237152A1/en
Publication of JP2021527104A publication Critical patent/JP2021527104A/ja
Publication of JPWO2019237152A5 publication Critical patent/JPWO2019237152A5/ja
Publication of JP2021527104A5 publication Critical patent/JP2021527104A5/ja
Application granted granted Critical
Publication of JP7385930B2 publication Critical patent/JP7385930B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2020569792A 2018-06-15 2019-06-12 サトウキビ由来の全植物繊維抽出物を使用した炎症性腸疾患の治療のための製剤 Active JP7385930B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
AU2018902145 2018-06-15
AU2018902145A AU2018902145A0 (en) 2018-06-15 Preparation for the Treatment of Inflammatory Bowel Disease using a Whole Plant Fibre Extract from Sugarcane
PCT/AU2019/050604 WO2019237152A1 (en) 2018-06-15 2019-06-12 Preparation for the treatment of inflammatory bowel disease using a whole plant fibre extract from sugarcane

Publications (4)

Publication Number Publication Date
JP2021527104A JP2021527104A (ja) 2021-10-11
JPWO2019237152A5 JPWO2019237152A5 (https=) 2022-06-10
JP2021527104A5 true JP2021527104A5 (https=) 2022-06-10
JP7385930B2 JP7385930B2 (ja) 2023-11-24

Family

ID=68841796

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2020569792A Active JP7385930B2 (ja) 2018-06-15 2019-06-12 サトウキビ由来の全植物繊維抽出物を使用した炎症性腸疾患の治療のための製剤

Country Status (6)

Country Link
US (1) US20210138002A1 (https=)
EP (1) EP3806879A4 (https=)
JP (1) JP7385930B2 (https=)
AU (1) AU2019285375B2 (https=)
CA (1) CA3103831A1 (https=)
WO (1) WO2019237152A1 (https=)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11241403B2 (en) 2016-03-11 2022-02-08 Axcess Global Sciences, Llc Beta-hydroxybutyrate mixed salt compositions and methods of use
US11103470B2 (en) 2017-11-22 2021-08-31 Axcess Global Sciences, Llc Non-racemic beta-hydroxybutyrate compounds and compositions enriched with the R-enantiomer and methods of use
US11185518B2 (en) 2017-12-19 2021-11-30 Axcess Global Sciences, Llc S-beta-hydroxybutyrate compounds and compositions enriched with S-enantiomer
US10973786B2 (en) 2016-03-11 2021-04-13 Axcess Global Sciences, Llc R-beta-hydroxybutyrate, S-beta-hydroxybutyrate, and RS-beta-hydroxybutyrate mixed salt compositions
US10973792B2 (en) 2019-02-13 2021-04-13 Axcess Global Sciences, Llc Racemic beta-hydroxybutyrate mixed salt-acid compositions and methods of use
US10736861B2 (en) 2016-03-11 2020-08-11 Axcess Global Sciences, Llc Mixed salt compositions for producing elevated and sustained ketosis
US12109182B2 (en) 2016-04-19 2024-10-08 Axcess Global Sciences, Llc Administration of R-beta-hydroxybutyrate and related compounds in humans
US11806324B2 (en) 2018-04-18 2023-11-07 Axcess Global Sciences, Llc Beta-hydroxybutyric acid compositions and methods for oral delivery of ketone bodies
US12599579B2 (en) 2016-04-19 2026-04-14 Axcess Global Sciences, Llc Compositions and compounds containing ketone bodies and/or ketone body precursors and one or more amino acids
US12496283B2 (en) 2016-04-19 2025-12-16 Axcess Global Sciences, Llc Administration of R-beta-hydroxybutyrate and related compounds in humans
US11202769B2 (en) 2017-11-22 2021-12-21 Axcess Global Sciences, Llc Ketone body esters of s-beta-hydroxybutyrate and/or s-1,3-butanediol for modifying metabolic function
US20230346721A1 (en) 2018-04-18 2023-11-02 Axcess Global Sciences, Llc Beta-hydroxybutyric acid compositions and methods for delivery of ketone bodies
US11944598B2 (en) 2017-12-19 2024-04-02 Axcess Global Sciences, Llc Compositions containing s-beta-hydroxybutyrate or non-racemic mixtures enriched with the s-enatiomer
US12329734B2 (en) 2017-12-19 2025-06-17 Axcess Global Sciences, Llc Use of S-beta-hydroxybutyrate compounds for induction and maintenance of flow
US12521378B2 (en) 2016-04-19 2026-01-13 Axcess Global Sciences, Llc Administration of R-beta-hydroxybutyrate salt blend and related compounds in humans
US10925843B2 (en) 2018-04-18 2021-02-23 Axcess Global Sciences, Llc Compositions and methods for keto stacking with beta-hydroxybutyrate and acetoacetate
US12533346B2 (en) 2016-04-19 2026-01-27 Axcess Global Sciences, Llc Administration of berberine metabolites
US12090129B2 (en) 2017-11-22 2024-09-17 Axcess Global Sciences, Llc Non-racemic beta-hydroxybutyrate compounds and compositions enriched with the R-enantiomer and methods of use
US11129802B2 (en) 2018-08-27 2021-09-28 Axcess Global Sciences, Llc Compositions and methods for delivering cannabidiol and ketone bodies
US11241401B2 (en) 2020-02-06 2022-02-08 Axcess Global Sciences, Llc Enantiomerically pure r-beta-hydroxybutyrate mixed salt-acid compositions
US11419836B2 (en) 2019-02-13 2022-08-23 Axcess Global Sciences, Llc Racemic and near racemic beta-hydroxybutyrate mixed salt-acid compositions
US10980772B2 (en) 2018-08-27 2021-04-20 Axcess Global Sciences, Llc Compositions and methods for delivering tetrahydrocannabinol and ketone bodies
US12472200B2 (en) * 2019-05-15 2025-11-18 Axcess Global Sciences, Llc Autobiotic compositions and method for promoting healthy gut microbiome
US12167993B2 (en) 2019-06-21 2024-12-17 Axcess Global Sciences, Llc Non-vasoconstricting energy-promoting compositions containing ketone bodies
US11969430B1 (en) 2023-03-10 2024-04-30 Axcess Global Sciences, Llc Compositions containing paraxanthine and beta-hydroxybutyrate or precursor for increasing neurological and physiological performance
US11950616B2 (en) 2019-06-21 2024-04-09 Axcess Global Sciences, Llc Non-vasoconstricting energy-promoting compositions containing ketone bodies
US11033553B2 (en) 2019-06-21 2021-06-15 Axcess Global Sciences, Llc Non-vasoconstricting energy-promoting compositions containing ketone bodies
US12186297B2 (en) 2020-08-26 2025-01-07 Axcess Global Sciences, Llc Compositions and methods for increasing lean-to-fat mass ratio
WO2024026529A1 (en) * 2022-08-01 2024-02-08 Health Food Symmetry Pty Ltd Preparation for the treatment of non-alcoholic fatty liver disease (nafld)
BE1031643B1 (nl) * 2023-05-26 2025-01-03 Synero Bv Functionele drank alsook werkwijze voor het vervaardigen en stabiliseren hiervan

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NO320546B1 (no) * 2003-12-12 2005-12-19 Nova Biotics As Prebiotiske kombinasjonsprodukter
US20060093592A1 (en) * 2004-10-04 2006-05-04 Nutracea Synbiotics
US20080227753A1 (en) 2007-02-26 2008-09-18 Kun Lian Nano-sized Bagasse Fiber
US9245263B2 (en) * 2009-06-23 2016-01-26 Jwl Ip Holdings Llc Systems and methods for scripted content delivery
AU2010300088A1 (en) 2009-09-23 2012-05-17 Kfsu Pty Ltd The production of fibre from plant material
PL2515937T3 (pl) 2009-12-22 2020-05-18 Probi Ab Niesfermentowane kompozycje zawierające frakcję zbożową i probiotyk oraz ich zastosowania
JP6549376B2 (ja) 2012-03-05 2019-07-24 グラタク テクノロジーズ ピーティーワイ リミテッド 栄養補助食品
US20160067299A1 (en) * 2013-04-05 2016-03-10 Gratuk Technologies Pty Ltd Use of dietary fibre supplement in a food formulation
CN103355728A (zh) * 2013-07-01 2013-10-23 福建省农业科学院农业工程技术研究所 一种果汁的固定化半连续乳酸发酵方法
AU2014349787A1 (en) * 2013-11-18 2016-07-07 Kfsu Ltd Dietary supplement for the treatment of acid reflux and gastro-oesophageal reflux disease (GORD/GERD)
JP5852207B2 (ja) 2013-11-29 2016-02-03 喜信 大城 サトウキビの難消化性食物繊維の製造方法
JP2015202057A (ja) 2014-04-11 2015-11-16 喜信 大城 食物繊維入りヨーグルトの製造方法
JP6306170B2 (ja) * 2014-05-24 2018-04-04 アテリオ・バイオ株式会社 難消化性物質及びその製造方法
US10245294B2 (en) * 2014-06-13 2019-04-02 Gratuk Technologies Pty Ltd Dietary supplement
CN104814365A (zh) * 2015-05-29 2015-08-05 郭心仪 鹅饲料的制备方法
CN105685486A (zh) * 2016-01-29 2016-06-22 刘健 一种天然高纤维无臭型牛羊饲料的制备方法
CN106883968A (zh) * 2017-04-24 2017-06-23 贵州省仁怀市茅台镇永泰酒业股份有限公司 一种杨梅果酒生产方法

Similar Documents

Publication Publication Date Title
JP2021527104A5 (https=)
JPWO2019237152A5 (https=)
JP2021078504A5 (https=)
JP2013517784A5 (https=)
RU2012118639A (ru) ШТАММЫ Lactobacillus plantarum В КАЧЕСТВЕ ГИПОХОЛЕСТЕРИНЕМИЧЕСКИХ АГЕНТОВ
JP2019508486A5 (https=)
JP2016529309A5 (https=)
RU2018139655A (ru) Бифидобактерии для увеличения безжировой массы тела
Panebianco et al. Microbiota manipulation by probiotics administration as emerging tool in cancer prevention and therapy
JP2018039833A5 (https=)
Zhang et al. Antagonistics against pathogenic Bacillus cereus in milk fermentation by Lactobacillus plantarum ZDY2013 and its anti-adhesion effect on Caco-2 cells against pathogens
JP2013537431A5 (https=)
JP2017537156A5 (https=)
JP2020520916A5 (https=)
JP2016537410A5 (https=)
JP2019535828A5 (https=)
MY187060A (en) Bifidobacteria as probiotic foundation species of gut microbiota
HRP20210780T1 (hr) Pripravci koji sadrže bakterijske sojeve
JP2016530291A5 (https=)
JP2015525566A5 (https=)
JP2017081853A (ja) ウイルス感染症の予防及び/又は治療剤
RU2017110516A (ru) Фармацевтические и пищевые композиции для индукции насыщения и продления чувства сытости у нуждающихся в этом субъектов
Kang et al. A recombinant Bifidobacterium bifidum BGN4 strain expressing the streptococcal superoxide dismutase gene ameliorates inflammatory bowel disease
WO2016159593A9 (ko) 락토코커스 중앙젠시스를 유효성분으로 함유하는 염증성 질환의 예방 또는 치료용 약학적 조성물
WO2007144083A3 (de) Ache-nmda-kombinationswafer